| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | Director | Restricted Stock Units | 178,086 | 12 Jan 2026 | Direct | ||
| Eton Pharmaceuticals, Inc. | Director | Employee Stock Option (Right to Buy) | 170,329 | 12 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | 12 Jan 2026 | 2 | $0 | 4 | Director | 14 Jan 2026, 18:08 |
| ETON | Eton Pharmaceuticals, Inc. | 03 Jan 2025 | 1 | $0 | 4 | Director | 06 Jan 2025, 16:23 |
| ETON | Eton Pharmaceuticals, Inc. | 13 Feb 2024 | 1 | $0 | 4 | Director | 15 Feb 2024, 16:19 |
| ETON | Eton Pharmaceuticals, Inc. | 03 Mar 2023 | 1 | $0 | 4 | Director | 03 Mar 2023, 15:10 |
| ETON | Eton Pharmaceuticals, Inc. | 07 Feb 2022 | 1 | $0 | 4 | Director | 28 Feb 2022, 15:39 |